Expanding HERG Screening Market Fueled By Increasing Prevalence Of Heart Disorders: A Key Driver Powering HERG Screening Market Growth In 2025

The HERG Screening Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current HERG Screening Market Size and Its Estimated Growth Rate?
The market size for HERG screening has seen substantial growth in recent times. This market is poised to escalate from $1.62 billion in 2024 to $1.84 billion in 2025, registering a compound annual growth rate (CAGR) of 13.9%. The augmented growth during the historic period stems from intensified drug development initiatives, regulatory guidelines, heightened awareness towards cardiac health, and the increasing prevalence of heart disorders.

In the coming years, the HERG screening market's worth is anticipated to escalate quickly. Predictions indicate it will expand to $2.9 billion in 2029, increasing at a 12.0% compound annual growth rate (CAGR). The surge in this forecasted period is linked to factors including the growing emphasis on personalized medicine, an increase in outsourcing for drug development tasks, developing markets and research, and a shift towards non-cardiac safety evaluations. Throughout this predicted progression, the key trends are expected to be improvements in in vitro models, incorporating genomic and proteomic data, development in computational methodologies, focus on pediatric drug safety, and increased collaboration for data sharing and standardization.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14392

How Are Emerging Segments Shaping the HERG Screening Market Landscape?
The HERG screening market covered in this report is segmented -

1) By Type: Gene KCNH2, Mutant KCNH2
2) By Ion Channel: Voltage-Gated, Ligand Gated
3) By Applications: Antiarrhythmic, Antipsychotic, Antibiotics, Other Applications

Subsegmeents:
1) By Gene KCNH2: Wild-Type KCNH2, Recombinant KCNH2
2) By Mutant KCNH2: Mutations: Missense Mutations, Nonsense Mutations, Frameshift Mutations

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14392&type=smp

Which Growth Factors Are Influencing HERG Screening Market Expansion?
The HERG screening market is projected to experience significant growth due to the increasing number of individuals experiencing heart related conditions. Heart disorders, also referred to as cardiovascular diseases, encompass a variety of conditions affecting heart function and the vascular system. Unhealthy lifestyles, an aging demographic, genetic predispositions, diabetes, and metabolic syndrome contribute to these conditions. HERG screening facilitates the identification of viable drug candidates, helps to prevent adverse cardiac events that may lead to fatal cardiac arrhythmias, specifically torsade de pointes (TdP), and optimizes patient prognosis. A report from the US-based Centers for Disease Control and Prevention in May 2023, shows that 1 in 20 adults over the age of 20 had cardiovascular diseases with 695,000 cases and 375,476 mortalities. Moreover, a report from the UK-based Office for National Statistics in March 2022 indicates that 20,061 people died from heart attacks, marking an increase from the previous year. Consequently, the growing prevalence of heart disorders is fuelling the expansion of the HERG screening market.

Who Are the Dominant Players Across Different HERG Screening Market Segments?
Major companies operating in the HERG screening market are Eurofins-Cerep SA., Aviva Biosciences Inc., AstraZeneca Public Limited Company, Merck KGaA, Charles River Laboratories Inc., Abcam Public Limited Company, Molecular Devices LLC, Caliper Life Sciences Inc., Crprotex Limited, ChanTest Corporation, Creative bioarray Inc., Cellular Dynamics International Inc., Nanion Technologies, Essen Bioscience, ABR-Affinity BioReagents Inc., ACEA Biosciences Inc., Metrion biosciences Inc., Aurora Biomed Inc., Aureus Sciences, RedShift BioAnalytics, B'SYS GmbH, Cambridge Bioscience Ltd., Sophion Bioscience Inc., Fluxion Biosciences Inc., ChemAxon Ltd.

What HERG Screening Market Trends Are Gaining Traction Across Different Segments?
Innovative advanced solutions, including GLP-certified HERG screening services, are being prioritized by leading companies in the HERG screening market for improved cardiac safety evaluations during pharmaceutical trials. This entails using the conventional whole-cell patch-clamp procedure for good laboratory practice-certified screening of the human ether-à-go-go related gene (hERG) in line with regulatory standards such as ICH S7A and ICH S7B. These standards are crucial for safety pharmacology experiments in drug creation. As an example, Metrion Biosciences Ltd., a pharmaceutical firm from the UK, announced the rolling out of their GLP-certified hERG screening service in August 2023. The objective of this service is to augment Metrion's contribution to the development of small-molecule treatment, and further strengthen their cardiac safety service offerings. Additionally, it applies the traditional whole-cell patch-clamp method for evaluating potential cardiac risks prior to initiation of Phase 1 clinical experiments in humans. This service also offers regulatory advice for safety pharmacology research in drug development and delivers clients top-notch biology services for ion channel targets.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

Which Geographic Regions Are Expected to Dominate the HERG Screening Market in the Coming Years?
North America was the largest region in the HERG screening market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the HERG screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the HERG Screening Market?
2. What is the CAGR expected in the HERG Screening Market?
3. What Are the Key Innovations Transforming the HERG Screening Industry?
4. Which Region Is Leading the HERG Screening Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.